Taiwanese Journal of Obstetrics and Gynecology
Volume 46, Issue 2 , Pages 135-145, June 2007

The Interactions Between GPR30 and the Major Biomarkers in Infiltrating Ductal Carcinoma of the Breast in an Asian Population

  • Wen-Hung Kuo

      Affiliations

    • Department of Surgery, National Taiwan University Hospital, Taipei, Taiwan
    • Angiogenesis Research Center, National Taiwan University, Taipei, Taiwan
    • ,
  • Li-Yun Chang

      Affiliations

    • Department of Obstetrics and Gynecology, National Taiwan University Hospital, Taipei, Taiwan
    • ,
  • Daisy Li-Yu Liu

      Affiliations

    • Biometrics Division, Department of Agronomy, National Taiwan University, Taipei, Taiwan
    • ,
  • Hsiao-Lin Hwa

      Affiliations

    • Department of Obstetrics and Gynecology, National Taiwan University Hospital, Taipei, Taiwan
    • ,
  • Jen-Jen Lin

      Affiliations

    • Department of Applied Statistics and Information Science, Ming Chuan University, Taipei, Taiwan
    • ,
  • Po-Huang Lee

      Affiliations

    • Department of Surgery, National Taiwan University Hospital, Taipei, Taiwan
    • Angiogenesis Research Center, National Taiwan University, Taipei, Taiwan
    • ,
  • Chiung-Nien Chen

      Affiliations

    • Department of Surgery, National Taiwan University Hospital, Taipei, Taiwan
    • Angiogenesis Research Center, National Taiwan University, Taipei, Taiwan
    • Division of Mechanics, Research Center for Applied Sciences, Academia Sinica, Taipei, Taiwan
    • ,
  • Huang-Chun Lien

      Affiliations

    • Department of Pathology, National Taiwan University Hospital, Taipei, Taiwan
    • ,
  • Ray-Hwang Yuan

      Affiliations

    • Department of Surgery, National Taiwan University Hospital, Taipei, Taiwan
    • ,
  • Chia-Tung Shun

      Affiliations

    • Department of Pathology, National Taiwan University Hospital, Taipei, Taiwan
    • ,
  • King-Jen Chang

      Affiliations

    • Department of Surgery, National Taiwan University Hospital, Taipei, Taiwan
    • Angiogenesis Research Center, National Taiwan University, Taipei, Taiwan
    • ,
  • Fon-Jou Hsieh

      Affiliations

    • Department of Obstetrics and Gynecology, National Taiwan University Hospital, Taipei, Taiwan
    • Graduate Institute of Clinical Research, National Taiwan University Hospital, Taipei, Taiwan
    • Department of Life Science, National Taiwan University, Taipei, Taiwan
    • Center of Systems Biology and Bioinformatics, National Taiwan University, Taipei, Taiwan
    • Corresponding Author InformationCorrespondence to: Dr Fon-Jou Hsieh, Department of Obstetrics and Gynecology, College of Medicine, National Taiwan University Hospital, 7, Chung-Shan South Road, Taipei 100, Taiwan

Accepted 12 March 2007.

Article Outline

Summary 

Objective

G-protein-coupled receptor 30 (GPR30) has been reported to be a novel estrogen receptor a (ERa) in vitro. Therefore, the interactions among GPR30, ERa, progesterone receptor (PR) and human epidermal growth factor receptor-2 (HER-2/neu), and their prognostic utilities in the infiltrating ductal carcinoma (IDC) of the breast were evaluated.

Materials and Methods

Messenger RNA (mRNA) levels of GPR30, ERa, PR and HER-2/neu in the tumor samples of 118 Taiwanese IDC patients and 27 non-tumor mammary tissues were measured via quantitative polymerase chain reaction analyses. The correlations of GPR30 mRNA levels with clinical parameters, i.e. tumor/non-tumor, ERa, PR, HER-2/neu, age, lymph node metastasis, lymph–vascular invasion, grade, stage and patient survival, were assessed by using appropriate statistical analyses.

Results

GPR30 expression was observed to be lower in IDC (p < 0.001) than in non-tumor mammary tissues. Importantly, GPR30 mRNA level was positively correlated with that of ERa (p = 0.001) and PR (p = 0.001) but not correlated with that of HER-2/neu when they were analyzed as continuous variables. However, lower GPR30 was noticed in tumors with HER-2/neu protein overexpression. GPR30 expression was not correlated with age, lymph node metastasis, lymph–vascular invasion, grade and stage in IDC. GPR30 expression was not an independent prognostic factor for patient survival.

Conclusion

GPR30 expression is downregulated in IDC. GPR30 is preferentially co-expressed with ER and/or PR but is lowly expressed in HER-2/neu(+) tumors. The correlation of GPR30 expression with clinical parameters, including patient survival, was not evident in this cohort.

Key Words:  estrogen receptor α , G-protein-coupled receptor 30 , human epidermal growth factor receptor-2 , mRNA , progesterone receptor

No full text is available. To read the body of this article, please view the PDF online.

 

Back to Article Outline

References 

  1. Chen CJ , You SL , Lin LH , Hsu WL , Yang YW . Cancer epidemiology and control in Taiwan: a brief review . Jpn J Clin Oncol . 2002;32(Suppl 1):S66–S81
  2. Pike MC , Spicer DV , Dahmoush L , Press MF . Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk . Epidemiol Rev . 1993;15:17–35
  3. Carmeci C , Thompson DA , Ring HZ , Francke U , Weigel RJ . Identification of a gene (GPR30) with homology to the G-protein-coupled receptor superfamily associated with estrogen receptor expression in breast cancer . Genomics . 1997;45:607–617
  4. Kakinuma N , Sato M , Yamada T , et al.   Cloning of novel LERGU mRNAs in GPR30 3' untranslated region and detection of 2 bp-deletion polymorphism in gastric cancer . Cancer Sci . 2005;96:191–196
  5. Takada Y , Kato C , Kondo S , Korenaga R , Ando J . Cloning of cDNAs encoding G protein-coupled receptor expressed in human endothelial cells exposed to fluid shear stress . Biochem Biophys Res Commun . 1997;240:737–741
  6. Filardo EJ , Quinn JA , Frackelton AR , Bland KI . Estrogen action via the G-protein-coupled receptor, GPR30: stimulation of adenylyl cyclase and cAMP-mediated attenuation of the epidermal growth factor receptor-to-MAPK signaling axis . Mol Endocrinol . 2002;16:70–84
  7. Maggiolini M , Vivacqua A , Fasanella G , et al.   The G protein-coupled receptor GPR30 mediates c-fos up-regulation by 17b-estradiol and phytoestrogens in breast cancer cells . J Biol Chem . 2004;279:27008–27016
  8. Manavathi B , Kumar R . Steering estrogen signals from the plasma membrane to the nucleus: two sides of the coin . J Cell Physiol . 2006;207:594–604
  9. Revankar CM , Cimino DF , Sklar LA , Arterburn JB , Prossnitz ER . A transmembrane intracellular estrogen receptor mediates rapid cell signaling . Science . 2005;307:1625–1630
  10. Pedram A , Razandi M , Levin ER . Nature of functional estrogen receptors at the plasma membrane . Mol Endocrinol . 2006;20:1996–2009
  11. Bookout AL , Cummins CL , Kramer MF , Pesola JM , Mangelsdorf DJ . High-throughput real-time quantitative reverse transcription PCR . In:  Ausubel FM ,  Brent R ,  Kingston RE ,  Moore DDJ editor. Current Protocols in Molecular Biology . New Jersey: John Wiley and Sons; 2006;p. 15.8.1–15.828
  12. Kuehl RO . Statistical Principles of Research Design and Analysis . 2nd edition. Belmont (CA): Duxbury Press; 2000;
  13. Chambers J , Cleveland W , Kleiner B , Tukey P . Graphical Methods for Data Analysis . Belmont (CA): Wadsworth; 1983;
  14. Filardo EJ , Graeber CT , Quinn JA , et al.   Distribution of GPR30, a seven membrane-spanning estrogen receptor, in primary breast cancer and its association with clinicopatho-logic determinants of tumor progression . Clin Cancer Res . 2006;12:6359–6366
  15. Hudelist G , Czerwenka K , Kubista E , Marton E , Pischinger K , Singer CF . Expression of sex steroid receptors and their co-factors in normal and malignant breast tissue: AIB1 is a carcinoma-specific co-activator . Breast Cancer Res Treat . 2003;78:193–204
  16. Lapidus RG , Nass SJ , Davidson NE . The loss of estrogen and progesterone receptor gene expression in human breast cancer . J Mammary Gland Biol Neoplasia . 1998;3:85–94
  17. Leu YW , Yan PS , Fan M , et al.   Loss of estrogen receptor signaling triggers epigenetic silencing of downstream targets in breast cancer . Cancer Res . 2004;64:8184–8192
  18. Dubey S , Siegfried JM , Traynor AM . Non-small-cell lung cancer and breast carcinoma: chemotherapy and beyond . Lancet Oncol . 2006;7:416–424
  19. Daniel JM . Effects of oestrogen on cognition: what have we learned from basic research? . J Neuroendocrinol . 2006;18:787–795
  20. Dhandapani KM , Brann DW . Role of astrocytes in estrogen-mediated neuroprotection . Exp Gerontol . 2007;42:70–75
  21. Thakur MK , Sharma APK . Aging of brain: role of estrogen . Neurochem Res . 2006;31:1389–1398

PII: S1028-4559(07)60007-2

doi:10.1016/S1028-4559(07)60007-2

Taiwanese Journal of Obstetrics and Gynecology
Volume 46, Issue 2 , Pages 135-145, June 2007

Article Tools